Glioblastoma: pathology, molecular mechanisms and markers, Acta Neuropathologica, vol.132, issue.Suppl 4, pp.829-877, 2015. ,
DOI : 10.1242/dev.02162
Glioblastoma: From Molecular Pathology to Targeted Treatment, Annual Review of Pathology: Mechanisms of Disease, vol.9, issue.1, pp.1-25, 2014. ,
DOI : 10.1146/annurev-pathol-011110-130324
<i>FGFR3-TACC3</i> fusion in solid tumors: mini review, Oncotarget, vol.7, issue.34, pp.55924-55962, 2016. ,
DOI : 10.18632/oncotarget.10482
URL : http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=10482&path%5B%5D=33118
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma, Clinical Cancer Research, vol.21, issue.14, pp.3307-3324, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-2199
URL : https://hal.archives-ouvertes.fr/hal-01317544
PLZF Regulates Fibroblast Growth Factor Responsiveness and Maintenance of Neural Progenitors, PLoS Biology, vol.450, issue.10, p.1001676, 2013. ,
DOI : 10.1371/journal.pbio.1001676.s010
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas, Clinical Cancer Research, vol.18, issue.19, pp.5203-5214, 2012. ,
DOI : 10.1158/1078-0432.CCR-12-0845
Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas. Neuro Oncol. Epub ahead print. doi: 10. 1093/neuonc/nox028 Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis, J Clin Oncol, vol.821, issue.20, pp.3798-807, 2003. ,
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway, Acta Neuropathol, vol.133, issue.3, pp.417-446, 2017. ,
The challenges associated with molecular targeted therapies for glioblastoma, Journal of Neuro-Oncology, vol.344, issue.1, pp.427-461, 2016. ,
DOI : 10.1016/j.canlet.2013.10.010
The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling Epithelioid GBMs show a high percentage of BRAF V600E mutation, Glia. Am J Surg Pathol, vol.6237, issue.125, pp.1328-44685, 2013. ,
Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes, WK (2016) WHO classification of tumours of the central nervous system, Revised. 4th update Edition, International Agency for Research On Cancer: Lyon. 16, pp.1200-1206, 2014. ,
Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, vol.5, issue.4, pp.557-72, 2004. ,
DOI : 10.1093/biostatistics/kxh008
Unique Expression Pattern of the FGF Receptor 3 Gene during Mouse Organogenesis, Developmental Biology, vol.155, issue.2, pp.423-453, 1993. ,
DOI : 10.1006/dbio.1993.1040
Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains, Development, vol.130, issue.1, pp.93-102, 2003. ,
DOI : 10.1242/dev.00184
URL : http://dev.biologists.org/content/develop/130/1/93.full.pdf
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, Acta Neuropathologica, vol.226, issue.3, pp.407-424, 2015. ,
DOI : 10.1002/path.2995
Neuro-oncology: Novel molecular targets in treatment of glioblastoma, Nature Reviews Neurology, vol.501, issue.11, pp.612-615, 2013. ,
DOI : 10.1038/nature12625
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas, Journal of Clinical Oncology, vol.27, issue.25, pp.4150-4154, 2009. ,
DOI : 10.1200/JCO.2009.21.9832
Transforming fusions of FGFR and TACC genes in human glioblastoma Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Science. Nature, vol.337, issue.60997216, pp.1231-1236, 2008. ,